OncoSec Medical Inc. Daily Stock Analysis

Daily Stock Analysis, ONCS, OncoSec Medical Inc, priceseries

OncoSec Medical Inc. Daily Stock Analysis
Stock Information
Open
0.96
Close
0.88
High
0.97
Low
0.88
Previous Close
0.96
Daily Price Gain
-0.08
YTD High
1.12
YTD High Date
Jan 14, 2022
YTD Low
0.75
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.11
YTD Gain
-11.11%
52 Week High
6.28
52 Week High Date
Mar 18, 2021
52 Week Low
0.75
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-4.22
52 Week Gain
-82.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 1. 2017
9.79
Sep 13. 2017
10.31
7 Trading Days
5.34%
Link
LONG
Oct 11. 2017
10.90
Oct 19. 2017
11.45
6 Trading Days
5.05%
Link
LONG
Aug 7. 2018
13.20
Aug 20. 2018
14.39
9 Trading Days
9.00%
Link
LONG
Jan 23. 2019
7.00
Feb 1. 2019
7.64
7 Trading Days
9.22%
Link
LONG
Mar 29. 2019
5.57
Apr 16. 2019
6.08
12 Trading Days
9.08%
Link
LONG
Apr 1. 2020
1.66
Apr 6. 2020
1.75
3 Trading Days
5.42%
Link
LONG
May 18. 2020
1.95
May 29. 2020
2.25
8 Trading Days
15.46%
Link
LONG
Jul 17. 2020
3.36
Jul 21. 2020
3.60
2 Trading Days
7.29%
Link
LONG
Aug 10. 2020
4.23
Aug 11. 2020
4.82
1 Trading Days
13.83%
Link
LONG
Nov 3. 2020
3.91
Nov 19. 2020
5.12
12 Trading Days
31.04%
Link
LONG
Dec 16. 2020
5.49
Dec 28. 2020
6.14
7 Trading Days
11.88%
Link
LONG
Dec 7. 2021
1.39
Dec 10. 2021
1.46
3 Trading Days
5.40%
Link
Company Information
Stock Symbol
ONCS
Exchange
NasdaqCM
Company URL
http://www.oncosec.com
Company Phone
(858) 210-7333
CEO
Punit S. Dhillon
Headquarters
California
Business Address
5820 NANCY RIDGE DRIVE, SAN DIEGO, CA 92121
Sector
-
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001444307
About

OncoSec Medical, Inc. engages in designing, developing and commercializing medical products for the treatment of cancer. It engages in the discovery and development of novel immunotherapeutic products to improve treatment options for patients and physicians, which intends to treat oncology indications. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in San Diego, CA.

Description

OncoSec Medical Incorporated, a biotechnology company, designs, develops, and commercializes gene therapies, therapeutics, and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. Its lead product candidate is the ImmunoPulse IL-12, which is in Phase II clinical trial for various indications, including metastatic melanoma and triple negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company's therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer. The company also has completed two Phase II studies for products, such as OMS-I100 in metastatic melanoma and OMS-I110 in merkel cell carcinoma. It has a clinical collaboration with the University of California, San Francisco to evaluate the safety and efficacy of ImmunoPulse IL-12 in combination with KEYTRUDA (pembrolizumab) in patients with low tumor-infiltrating lymphocyte. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading